| 【英語タイトル】Global Biopharmaceutical Third-party Logistics Market Size study & Forecast, by Supply Chain (Cold chain, Non-cold chain), by Service Type (Transportation, Warehousing and storage, Others) and Regional Analysis, 2022-2029
|
 | ・商品コード：BZW23FE0103
・発行会社（調査会社）：Bizwit Research & Consulting
・発行日：2023年2月8日
・ページ数：約200
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
・産業分野：物流
|
◆販売価格オプション
（消費税別）
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
|
❖ レポートの概要 ❖
Bizwit Research社の市場調査レポートでは、2021年に約1198億ドルであった世界のバイオ医薬品用3PL（サードパーティーロジスティクス）市場規模が、2022年から2029年の間に年平均5.9％成長する見込みです。当レポートは、バイオ医薬品用3PL（サードパーティーロジスティクス）の世界市場を広く調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、サプライチェーン別（コールドチェーン、非コールドチェーン）分析、サービス種類別（輸送、倉庫・保管、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの項目を記載しています。並びに、市場調査の対象企業には、DHL International GmbH、SF Express、United Parcel Service of America, Inc、AmerisourceBergen Corporation、DB Schenker、Kuehne and Nagelなどが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界バイオ医薬品用3PL（サードパーティーロジスティクス）市場規模：サプライチェーン別
- コールドチェーンにおける市場規模
- 非コールドチェーンにおける市場規模
・世界バイオ医薬品用3PL（サードパーティーロジスティクス）市場規模：サービス種類別
- 輸送サービスにおける市場規模
- 倉庫・保管サービスにおける市場規模
- その他サービスにおける市場規模
・世界のバイオ医薬品用3PL（サードパーティーロジスティクス）市場規模：地域別
- 北米のバイオ医薬品用3PL（サードパーティーロジスティクス）市場
- ヨーロッパのバイオ医薬品用3PL（サードパーティーロジスティクス）市場
- アジア太平洋のバイオ医薬品用3PL（サードパーティーロジスティクス）市場
- 中南米のバイオ医薬品用3PL（サードパーティーロジスティクス）市場
- その他地域のバイオ医薬品用3PL（サードパーティーロジスティクス）市場
・競争分析
・調査プロセス |
Global Biopharmaceutical Third-party Logistics Market is valued at approximately USD 119.8 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2022-2029. Biopharmaceutical Third-party Logistics is referred to as a facility that helps in delivering precise therapies on time to medical clinics, pharmacies, hospitals, and physician practices. They also provide support to various companies such as pharmaceutical, biotech, and medical device along with carefully coordinating the fulfillment and distribution of the required products on time. The growing trend of outsourcing logistics, favorable government initiatives, and increasing technological developments are primary factors that are fostering the growth of the global market.
The flourishing development of the biopharmaceutical industry is directly associated with the growth of the Biopharmaceutical Third-party Logistics Market. According to a Statista analysis, in 2018 the global biopharmaceutical industry was estimated to be worth around USD 5.28 trillion and in 2021, the amount rises to USD 7.15 trillion. Consequentially, the development of the biopharmaceutical industry is positively influencing the growth of Biopharmaceutical Third-party Logistics Market across the globe. Moreover, the rising globalization and trade activities and a rise in the demand for cold chain logistics are anticipated to act as catalyzing factors for the market demand during the forecast period. However, the dearth of logistics professionals and lack of control of shippers on logistics services impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the Global Biopharmaceutical Third-party Logistics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the high expenditure on healthcare services and presence of major players. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing demand for medicines among the aging population, and rising proliferation of technologically advanced services in the market space.
Major market players included in this report are:
DHL International GmbH
SF Express
United Parcel Service of America, Inc
AmerisourceBergen Corporation
DB Schenker
Kuehne and Nagel
Kerry Logistics Network Ltd.
Agility Logistics
McKesson Corporation
FedEx Corporation
Recent Developments in the Market:
In August 2020, United Parcel Service of America, Inc. declared that the company is developing its two big freezer farms competent for super-cooling lakhs COVID-19 vaccine doses to pre-prepare for the day medicine is needed to be delivered at high speed worldwide.
Global Biopharmaceutical Third-party Logistics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Supply Chain, Service Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Supply Chain:
Cold chain
Non-cold chain
By Service Type:
Transportation
Warehousing and storage
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Biopharmaceutical Third-party Logistics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Biopharmaceutical Third-party Logistics Market, by Supply Chain, 2019-2029 (USD Billion)
1.2.3. Biopharmaceutical Third-party Logistics Market, by Service Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Biopharmaceutical Third-party Logistics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Biopharmaceutical Third-party Logistics Market Dynamics
3.1. Biopharmaceutical Third-party Logistics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing trend of outsourcing logistics
3.1.1.2. Flourishing development of the biopharmaceutical industry
3.1.2. Market Challenges
3.1.2.1. Dearth of logistics professionals
3.1.2.2. Lack of control of shippers on logistics service
3.1.3. Market Opportunities
3.1.3.1. Rising globalization and trade activities
3.1.3.2. Rise in the demand for cold chain logistics
Chapter 4. Global Biopharmaceutical Third-party Logistics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Biopharmaceutical Third-party Logistics Market, by Supply Chain
6.1. Market Snapshot
6.2. Global Biopharmaceutical Third-party Logistics Market by Supply Chain, Performance – Potential Analysis
6.3. Global Biopharmaceutical Third-party Logistics Market Estimates & Forecasts by Supply Chain 2019-2029 (USD Billion)
6.4. Biopharmaceutical Third-party Logistics Market, Sub Segment Analysis
6.4.1. Cold chain
6.4.2. Non-cold chain
Chapter 7. Global Biopharmaceutical Third-party Logistics Market, by Service Type
7.1. Market Snapshot
7.2. Global Biopharmaceutical Third-party Logistics Market by Service Type, Performance – Potential Analysis
7.3. Global Biopharmaceutical Third-party Logistics Market Estimates & Forecasts by Service Type 2019-2029 (USD Billion)
7.4. Biopharmaceutical Third-party Logistics Market, Sub Segment Analysis
7.4.1. Transportation
7.4.2. Warehousing and storage
7.4.3. Others
Chapter 8. Global Biopharmaceutical Third-party Logistics Market, Regional Analysis
8.1. Biopharmaceutical Third-party Logistics Market, Regional Market Snapshot
8.2. North America Biopharmaceutical Third-party Logistics Market
8.2.1. U.S. Biopharmaceutical Third-party Logistics Market
8.2.1.1. Supply Chain breakdown estimates & forecasts, 2019-2029
8.2.1.2. Service Type breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Biopharmaceutical Third-party Logistics Market
8.3. Europe Biopharmaceutical Third-party Logistics Market Snapshot
8.3.1. U.K. Biopharmaceutical Third-party Logistics Market
8.3.2. Germany Biopharmaceutical Third-party Logistics Market
8.3.3. France Biopharmaceutical Third-party Logistics Market
8.3.4. Spain Biopharmaceutical Third-party Logistics Market
8.3.5. Italy Biopharmaceutical Third-party Logistics Market
8.3.6. Rest of Europe Biopharmaceutical Third-party Logistics Market
8.4. Asia-Pacific Biopharmaceutical Third-party Logistics Market Snapshot
8.4.1. China Biopharmaceutical Third-party Logistics Market
8.4.2. India Biopharmaceutical Third-party Logistics Market
8.4.3. Japan Biopharmaceutical Third-party Logistics Market
8.4.4. Australia Biopharmaceutical Third-party Logistics Market
8.4.5. South Korea Biopharmaceutical Third-party Logistics Market
8.4.6. Rest of Asia Pacific Biopharmaceutical Third-party Logistics Market
8.5. Latin America Biopharmaceutical Third-party Logistics Market Snapshot
8.5.1. Brazil Biopharmaceutical Third-party Logistics Market
8.5.2. Mexico Biopharmaceutical Third-party Logistics Market
8.5.3. Rest of Latin America Biopharmaceutical Third-party Logistics Market
8.6. Rest of The World Biopharmaceutical Third-party Logistics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. DHL International GmbH
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. SF Express
9.2.3. United Parcel Service of America, Inc
9.2.4. AmerisourceBergen Corporation
9.2.5. DB Schenker
9.2.6. Kuehne and Nagel
9.2.7. Kerry Logistics Network Ltd.
9.2.8. Agility Logistics
9.2.9. McKesson Corporation
9.2.10. FedEx Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
